Waters Corporation to Present at the TD Cowen Health Care Conference
Rhea-AI Summary
Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D., President and CEO, will speak in a fireside chat at the TD Cowen Health Care Conference on March 2, 2026 at 11:10 AM ET.
A live webcast will stream on the company's Events & Presentations investor site and a replay will be available for 90 days.
AI-generated analysis. Not financial advice.
Positive
- None.
Negative
- None.
News Market Reaction – WAT
On the day this news was published, WAT declined 0.45%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
WAT gained 1.42% with below-average volume while several diagnostics peers also showed gains (e.g., DGX +2.69%, ILMN
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Feb 17 | Product launch | Positive | -0.6% | Introduced higher-sensitivity MaxPeak Premier microflow LC columns with lower sample use. |
| Feb 09 | Business combination | Positive | -13.9% | BD completed spin-off and combination of its Biosciences & Diagnostic Solutions unit with Waters. |
| Feb 09 | Business combination | Positive | -13.9% | Waters closed its combination with BD businesses, creating four new operating divisions. |
| Feb 09 | Earnings & guidance | Positive | -13.9% | Reported Q4 and 2025 growth with 2026 revenue and EPS guidance including BD acquisition impact. |
| Jan 27 | Spin-off planning | Positive | -0.2% | BD set record date and detailed planned Reverse Morris Trust combination with Waters. |
Recent WAT news, including a large business combination and strong earnings/guidance, was followed by negative 24-hour price reactions despite generally positive strategic content.
Over the past month, Waters reported Q4 and full-year 2025 results with sales of $932 million for Q4 and $3,165 million for 2025, alongside 2026 revenue and EPS guidance. The company completed a major combination with BD’s Biosciences & Diagnostic Solutions businesses, creating a broader life sciences and diagnostics platform, and launched next-generation microflow LC columns. Despite these milestones, 24-hour price reactions were negative across all five recent events, highlighting a pattern of near-term selling into positive strategic and financial announcements ahead of today’s conference participation news.
Market Pulse Summary
This announcement highlights Waters’ investor outreach as its CEO joins a fireside chat at the TD Cowen Health Care Conference on March 2, 2026. Set against recent milestones—closing the BD Biosciences and Diagnostic Solutions combination and issuing 2026 revenue guidance of $6.41–$6.46 billion—the event offers a platform to elaborate on integration, growth priorities, and diagnostics strategy. Investors may watch for any updated commentary versus prior earnings and regulatory disclosures.
Key Terms
antibiotic resistance medical
AI-generated analysis. Not financial advice.
A live webcast of the event will be available on the 'Events & Presentations' section of Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will be available for 90 days.
About Waters Corporation
Waters Corporation (NYSE: WAT) is a global leader in life sciences and diagnostics, dedicated to accelerating the benefits of pioneering science through analytical technologies, informatics, and service. With a focus on regulated, high-volume testing environments, our innovative portfolio harnesses deep scientific expertise across chemistry, physics, and biology. We collaborate with customers around the world to advance the release of effective, high-quality medicines, ensure the safety of food and water, and drive better patient outcomes by detecting diseases earlier, managing routine infections, and combating antibiotic resistance. Through a shared culture of relentless innovation, our passionate team of ~16,000 colleagues turn scientific challenges into breakthroughs that improve lives worldwide. For more information, please visit www.waters.com/about.
Caspar Tudor, Head of Investor Relations
investor_relations@waters.com
View original content:https://www.prnewswire.com/news-releases/waters-corporation-to-present-at-the-td-cowen-health-care-conference-302694987.html
SOURCE Waters Corporation